Botox for the prevention of radiation‐induced Sialadenitis and xerostomia in head and neck cancer patients: A pilot study
暂无分享,去创建一个
M. B. Gillespie | F. García-Godoy | Yanhui H Zhang | J. Gleysteen | D. Schwartz | Weiqiang Zhang | Michael J. Herr | C. Nieri | Kimberly Coca | Ezer H Benaim | Ezer H. Benaim
[1] M. Popescu,et al. Botulinum Toxin Use for Modulating Neuroimmune Cutaneous Activity in Psoriasis , 2022, Medicina.
[2] R. Baum,et al. Safety of High-Dose Botulinum Toxin Injections for Parotid and Submandibular Gland Radioprotection , 2022, Toxins.
[3] Y. Xin,et al. Mechanism, Prevention, and Treatment of Radiation-Induced Salivary Gland Injury Related to Oxidative Stress , 2021, Antioxidants.
[4] F. Valarelli,et al. Effect of botulinum toxin on quality of life of patients with chronic myofascial pain. , 2021, Pain Management.
[5] E. Pawlowska,et al. Comparison of Oral Health Impact Profile (OHIP-14) Values in Cancer Survivor Patients Treated Orthodontically with Either Rapid or Standard Duration Protocols of Treatment—A Prospective Case–Control Study , 2020, International journal of environmental research and public health.
[6] Lin Wang,et al. Botulinum toxin type A ameliorates adjuvant-arthritis pain by inhibiting microglial activation-mediated neuroinflammation and intracellular molecular signaling. , 2020, Toxicon : official journal of the International Society on Toxinology.
[7] Pietro Salvo,et al. Saliva sampling: Methods and devices. An overview , 2020 .
[8] R. Fisher,et al. Head and Neck Squamous Cell Carcinoma , 2020, Definitions.
[9] C. Danesi,et al. Clinical and sociodemographic factors associated with oral health‐related quality of life in survivors of head and neck cancer , 2020, Head & neck.
[10] V. Wu,et al. A Review on the Assessment of Radiation Induced Salivary Gland Damage After Radiotherapy , 2019, Front. Oncol..
[11] R. Laskawi,et al. Therapy of Sialorrhea with Botulinum Neurotoxin , 2019, Neurology and Therapy.
[12] A. Vissink,et al. Salivary Gland Hypofunction and Xerostomia in Head and Neck Radiation Patients. , 2019, Journal of the National Cancer Institute. Monographs.
[13] D. E. da Cruz Perez,et al. Effects of chronic treatment with botulinum toxin type A in salivary glands of rats: Histological and immunohistochemical analyses. , 2019, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[14] Eduardo Pons-Fuster,et al. Effectiveness of the Botulinum Toxin for Treating Sialorrhea in Patients with Parkinson’s Disease: A Systematic Review , 2019, Journal of clinical medicine.
[15] S. Porter,et al. Interventions for the management of radiotherapy-induced xerostomia and hyposalivation: A systematic review and meta-analysis. , 2017, Oral oncology.
[16] K. Strauch,et al. Safety and Efficacy of Botulinum Toxin to Preserve Gland Function after Radiotherapy in Patients with Head and Neck Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blinded Phase I Clinical Trial , 2016, PloS one.
[17] S. Nguyen,et al. Clinical and quality‐of‐life outcomes following gland‐preserving surgery for chronic sialadenitis , 2015, The Laryngoscope.
[18] D. Li,et al. Submandibular gland sparing in intensity-modulated radiotherapy for N0-stage nasopharyngeal carcinoma. , 2014, The British journal of radiology.
[19] P. Burke,et al. Nutritional considerations for head and neck cancer patients: a review of the literature. , 2013, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[20] Li-Ling Wu,et al. Botulinum toxin A inhibits salivary secretion of rabbit submandibular gland , 2013, International Journal of Oral Science.
[21] Q. Le,et al. Botulinum Toxin Confers Radioprotection in Murine Salivary Glands. , 2013, International journal of radiation oncology, biology, physics.
[22] R. Burd,et al. Prevention of Radiation-Induced Salivary Gland Dysfunction Utilizing a CDK Inhibitor in a Mouse Model , 2012, PloS one.
[23] M. Krečmerová,et al. Lipases as Tools in the Synthesis of Prodrugs from Racemic 9-(2,3-Dihydroxypropyl)adenine , 2012, Molecules.
[24] S. Byun,et al. Effect of Botulinum Toxin Type A on Morphology of Salivary Glands in Patients with Cerebral Palsy , 2011, Annals of rehabilitation medicine.
[25] J. Werner,et al. Botulinum toxin prevents radiotherapy-induced salivary gland damage. , 2009, Oral oncology.
[26] M. Chancellor,et al. Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats. , 2009, European Urology.
[27] S. Leung,et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] S. Rogers,et al. A structured review and theme analysis of papers published on 'quality of life' in head and neck cancer: 2000-2005. , 2007, Oral oncology.
[29] R. Mandic,et al. Intraglandular application of botulinum toxin leads to structural and functional changes in rat acinar cells , 2007, British Journal of Pharmacology.
[30] Robert L. White,et al. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients. , 2006, The journal of supportive oncology.
[31] M. Crary,et al. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. , 2005, Archives of physical medicine and rehabilitation.
[32] W. Curran,et al. A phase II trial of subcutaneous amifostine and radiation therapy in patients with head and neck cancer. , 2001, Seminars in radiation oncology.
[33] R. Coppes,et al. Early to late sparing of radiation damage to the parotid gland by adrenergic and muscarinic receptor agonists , 2001, British Journal of Cancer.
[34] M. Navazesh,et al. Methods for Collecting Saliva , 1993, Annals of the New York Academy of Sciences.